XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Unrecognized Gains (Losses) on Derivative Instruments
Pension Obligations
Cumulative Translation Adjustment
Retained Earnings
Beginning of period at Dec. 31, 2021 $ (70,421) $ 103,214 $ (9,051) $ (6,133) $ (110,790) $ (47,661)
Beginning of the period (in shares) at Dec. 31, 2021   26,163,077        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 10,070         10,070
Change in unrecognized gains(losses) on derivative instruments, net of tax 16,821   16,821      
Change in defined benefit plans, net of taxes 83     83    
Net foreign currency translation adjustment 2,043       2,043  
Common stock issued, net of shares withheld for employee taxes (in shares)   690,215        
Stock-based compensation 1,002 $ 1,002        
Redeemable preferred 9% dividend and accretion (8,910)         (8,910)
European noncontrolling redeemable equity dividend (11)         (11)
End of period at Mar. 31, 2022 (49,323) $ 104,216 7,770 (6,050) (108,747) (46,512)
End of the period (in shares) at Mar. 31, 2022   26,853,292        
Beginning of period at Dec. 31, 2022 $ (25,297) $ 111,105 19,844 1,591 (110,704) (47,133)
Beginning of the period (in shares) at Dec. 31, 2022 27,016,125 27,016,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income $ (4,047)         (4,047)
Change in unrecognized gains(losses) on derivative instruments, net of tax 18,120   18,120      
Net foreign currency translation adjustment 14,631       14,631  
Common stock issued, net of shares withheld for employee taxes (in shares)   892,544        
Stock-based compensation (2,502) $ (2,502)        
Redeemable preferred 9% dividend and accretion (9,440)         (9,440)
European noncontrolling redeemable equity dividend (10)         (10)
End of period at Mar. 31, 2023 $ (8,545) $ 108,603 $ 37,964 $ 1,591 $ (96,073) $ (60,630)
End of the period (in shares) at Mar. 31, 2023 27,908,669 27,908,669